 |
GlaxoSmithKline Biologicals, Belgium
Pfizer, USA
Merck, USA
Novartis AG, Switzerland
Sanofi Pasteur, France
Sanofi-Aventis, France
MedImmune, USA
Baxter, USA
Novozymes A/S, Denmark
Wyeth, USA
Intercell, Austria
Crucell, Netherlands
VaxInnate, Inc., USA
Shenzhen Polytechnic, China
Medicago Inc, Canada
Novartis Vaccines, USA
Cyto Pulse Sciences, Inc., USA
GlaxoSmithKline Biologicals, USA
Selecta Biosciences Inc., USA
Petrovax Group, Russia
Becton,Dickinson&Company, USA
TechnoVax, USA
Antagen Biosciences, Inc., USA
Apogee Technology, Inc, USA
Acambis, UK
Chiron, USA
3M, USA
CSC, USA
AlphaVax, USA
Emergent BioSolutions, UK
Hawaii Biotech, USA
Arbovax, Inc, USA
PATH, USA
Sigma-Aldrich, USA
Duke-NUS, Singapore
TechnoVax, Inc., USA
Medicago Inc, Canada
Kotwal Bioconsulting, LLC, USA
MedImmune Vaccine, USA
Synergy America, Inc., USA
VPM Inc., Germany
Shanghai H&G Biotechnology Inc., China
Oxford-Emergent Tuberculosis Consortium Ltd, UK
Theraclone Sciences, Inc, USA
Green Cross Therapeutics Pvt Ltd, India
DanDrit Biotech, Denmark
Crossbeta Biosciences B.V., The Netherlands
Transgene S.A., France
TD Consultancy, LLC, USA
BioReliance, UK
Biosante Pharmaceuticals, USA
Vaxgen Corporation, USA
AXIO International, France
Charles River Avian Products and Services, USA
Strategic Manufacturing Worldwide, Inc., USA
GE Healthcare Life Sciences, Sweden
VTI Pharmaceutical Technologies (Shenzhen) Co., Ltd., China
GE Healthcare Life Sciences,China
Althea Technologies Inc., USA
immatics biotechnologies GmbH,Germany
Green Hills Biotechnology GmbH, Austria
Gan Shmuel, Israel
SIOGEN Biotech, Malaysia
OptiNose AS, Norway
Civimetrix, Canada
Apotex, Canada
Biovet Pvt Ltd, India
BD Technologies,
|
 |
 |
International Vaccine Institute
International AIDS Vaccine Institute
Global TB Vaccine Foundation
Bill & Melinda Gates Foundation, USA
Center for Disease Control and Prevention, China
Center for Disease Control and Prevention, USA
Children’s Global Health Initiative, USA
Vaccine and Infectious Disease Organization, Canada
Sabin Vaccine Institute, USA
National Institutes of Health , USA
National Human Genome Research, USA
National Vaccine and Serum Institute, China
Karolinska Institute, Sweden
Anderson Cancer Center, USA
Albert Einstein College of Medicine, USA
Oxford University, UK
Institute Pasteur, France
Tufts University, USA
Tufts University School of Medicine, USA
Fudan University, China
University of Missouri-Columbia, USA
Aarhus University Hospital – Skejby, Denmark
Baylor College of Medicine, USA
Fraunhofer USA CMB, USA
INSERM, France
Arizona State University, USA
Uppsala University. Sweden
US Army Medical Research Institute of Infectious Diseases, USA
Arizona State University, USA
University of Calgary, Canada
Gold Coast Campus, Australia
University of Calgary, Canada
National Health Research Institutes,Taiwan
Netherlands Vaccine Institute, Netherlands
Chungnam National University, Korea
The University of Sydney, Australia
Queen Mary University of London, UK
University of Lille2 and University of Artois, France
Ghent University, Belgium
Chicago Medical School, USA
National University of Colombia, Colombia
Army Medical Research Institute of Infectious Diseases, USA
European Commission Joint Research Center, Italy
University of Arkansas for Medical Sciences, USA
Mount Sinai School of Medicine, USA
University of New South Wales, Australia
Chinese Academy of Engineering, China
CrucellBerna Biotech Korea, Korea
Pomeranian Medical University, Poland
Public Health Service, The Netherlands
University of New South Wales, Australia
The Wistar Institute, USA
Kamineni Institute of Medical Sciences, India
RMIT University, Australia
National Taiwan University, Taiwan
University of Indonesia, Indonesia
World Health Organization, Switzerland
Russian Academy of Medical Sciences,Russian Federation
National Tsing Hua University, Taiwan
University of California, Davis, USA
Kuwait University, Kuwait
Lanzhou University, China
Texas Tech University Health Sciences Center, USA
Queensland Institute of Medical Research, Australia
French National Academy of Medicine, France
New York University, USA
Harvard Medical School, USA
Link?ping University, Sweden
D Cotugno Hospital, Italy
Chiang Mai University, Thailand
The Ohio State University, USA
Deakin University, Australia.
Vrije Universiteit Brussel, Belgium
University of Paris, France
University of Southampton, UK
University of Ulm, Germany
National Cancer Research Center, Serbia
World Health Organisation (WHO), Uganda
Cornell University, USA
Hacettepe University, Turkey
Tel Aviv University, Israe
National Institute of Hygiene, Morocco
|
 |
 |
|
|
|
|
|
| Conference 2010 |
 |
BIT Life Sciences’ 2nd Annual World Vaccine Congress-2010 focused Event for Vaccine Technology and associated with technologies for disease prevention and treatment was hold successfully in International Convention Center, Beijing, China during March 24-26, 2010. The conference was supported by China Medicinal Biotech Association (CMBA), P.R. China. This year’s congress has obtained highly focus and extensive attentions throughout the world. Honorable leaders and distinguished guests worldwide have come all the way to attend this congress. 43 sessions covered 8 fields including Basic Sciences of Preclinical Studies; Human Vaccines (Major Infectious Diseases); AIDS Vaccines; Human Vaccines(Non-Infectious Diseases); Cancer Vaccines; Livestock/Veterinary/ Aquaculture Vaccine R & D and so on. With a theme of “Next Generation Vaccines”, participants from academic, industrial professionals and key-decision makers delivered the new achievement on their research, together discussed and analysised the development of vaccine. There were in excess of 500 registrants from 40 countries, 260 abstracts, 33 exhibitors, 33 professional media altogether. Most of them registered for this congress as a group.
The participants of the conference had a good chance to hear from the renowned keynote speakers Dr. Roy Curtiss III, Academician, United States National Academy of Sciences, USA; Dr. John B Robbins, Senior Investigator, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA; Dr. Dexian Zheng, Vice President, Chinese Society for Immunolgy, China; Dr. Jeffrey Almond, Vice President, Global Research and External Research and Development, Sanofi-Pasteur, France; Dr. Jean-Paul Prieels, Senior Vice President, Research & Development, GlaxoSmithKline Biologicals, Belgium; Dr. Peter H. Khoury, Vice President, Global Marketing Baxter BioScience, Vaccines, USA.
Most participants gave a high appraisal to WCV-2010. According to the investigations after the conference, over 90% participants expressed that they would like to attend WCV-2011. Depending on the warmly support and good suggestions from all of the participants, we are confident in organizing WCV-2011 which would be better and more successful than WCV-2010. |
| |
|
|
|
|
|
| |
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
| Speakers' Photos |
| |
|